Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HN77
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 8 |
GO:0005509 | calcium ion binding | 5 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 174 | 178 | PF00656 | 0.498 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.543 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 109 | 113 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.506 |
CLV_PCSK_SKI1_1 | 263 | 267 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.341 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.281 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.437 |
CLV_Separin_Metazoa | 35 | 39 | PF03568 | 0.328 |
DOC_CYCLIN_RxL_1 | 205 | 213 | PF00134 | 0.515 |
DOC_CYCLIN_RxL_1 | 259 | 268 | PF00134 | 0.521 |
DOC_CYCLIN_RxL_1 | 50 | 60 | PF00134 | 0.344 |
DOC_MAPK_gen_1 | 87 | 97 | PF00069 | 0.535 |
DOC_PP2B_LxvP_1 | 127 | 130 | PF13499 | 0.468 |
DOC_WW_Pin1_4 | 70 | 75 | PF00397 | 0.691 |
LIG_14-3-3_CanoR_1 | 109 | 118 | PF00244 | 0.519 |
LIG_14-3-3_CanoR_1 | 9 | 17 | PF00244 | 0.704 |
LIG_APCC_ABBA_1 | 270 | 275 | PF00400 | 0.447 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.673 |
LIG_deltaCOP1_diTrp_1 | 46 | 52 | PF00928 | 0.449 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.518 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.440 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.545 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.691 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.544 |
LIG_FHA_2 | 131 | 137 | PF00498 | 0.559 |
LIG_FHA_2 | 224 | 230 | PF00498 | 0.398 |
LIG_FHA_2 | 3 | 9 | PF00498 | 0.593 |
LIG_LIR_Gen_1 | 128 | 135 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 148 | 157 | PF02991 | 0.211 |
LIG_LIR_Gen_1 | 191 | 201 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 268 | 276 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 128 | 134 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 148 | 152 | PF02991 | 0.223 |
LIG_LIR_Nem_3 | 191 | 197 | PF02991 | 0.392 |
LIG_LIR_Nem_3 | 268 | 273 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 70 | 75 | PF02991 | 0.671 |
LIG_MYND_3 | 103 | 107 | PF01753 | 0.295 |
LIG_Pex14_1 | 47 | 51 | PF04695 | 0.328 |
LIG_Pex14_2 | 194 | 198 | PF04695 | 0.427 |
LIG_PTB_Apo_2 | 217 | 224 | PF02174 | 0.454 |
LIG_PTB_Phospho_1 | 217 | 223 | PF10480 | 0.446 |
LIG_SH2_CRK | 72 | 76 | PF00017 | 0.733 |
LIG_SH2_STAP1 | 253 | 257 | PF00017 | 0.421 |
LIG_SH2_STAP1 | 32 | 36 | PF00017 | 0.328 |
LIG_SH2_STAT3 | 162 | 165 | PF00017 | 0.521 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.459 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.702 |
LIG_SH3_3 | 73 | 79 | PF00018 | 0.640 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.618 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.699 |
MOD_CK2_1 | 130 | 136 | PF00069 | 0.551 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.613 |
MOD_CK2_1 | 268 | 274 | PF00069 | 0.424 |
MOD_GlcNHglycan | 136 | 142 | PF01048 | 0.599 |
MOD_GlcNHglycan | 154 | 157 | PF01048 | 0.353 |
MOD_GlcNHglycan | 46 | 50 | PF01048 | 0.332 |
MOD_GlcNHglycan | 96 | 100 | PF01048 | 0.460 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.488 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.437 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.585 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.486 |
MOD_N-GLC_1 | 178 | 183 | PF02516 | 0.414 |
MOD_N-GLC_1 | 23 | 28 | PF02516 | 0.449 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.451 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.355 |
MOD_NEK2_1 | 45 | 50 | PF00069 | 0.363 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.446 |
MOD_NEK2_2 | 178 | 183 | PF00069 | 0.475 |
MOD_PIKK_1 | 10 | 16 | PF00454 | 0.704 |
MOD_PIKK_1 | 118 | 124 | PF00454 | 0.402 |
MOD_Plk_1 | 147 | 153 | PF00069 | 0.373 |
MOD_Plk_1 | 178 | 184 | PF00069 | 0.413 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.615 |
MOD_Plk_2-3 | 268 | 274 | PF00069 | 0.424 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.568 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.260 |
MOD_ProDKin_1 | 70 | 76 | PF00069 | 0.687 |
TRG_DiLeu_BaLyEn_6 | 196 | 201 | PF01217 | 0.521 |
TRG_DiLeu_BaLyEn_6 | 205 | 210 | PF01217 | 0.522 |
TRG_DiLeu_BaLyEn_6 | 260 | 265 | PF01217 | 0.399 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.413 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.702 |
TRG_ER_diArg_1 | 108 | 110 | PF00400 | 0.533 |
TRG_NES_CRM1_1 | 189 | 203 | PF08389 | 0.533 |
TRG_NES_CRM1_1 | 256 | 268 | PF08389 | 0.396 |
TRG_Pf-PMV_PEXEL_1 | 110 | 114 | PF00026 | 0.449 |
TRG_Pf-PMV_PEXEL_1 | 199 | 203 | PF00026 | 0.532 |
TRG_Pf-PMV_PEXEL_1 | 208 | 213 | PF00026 | 0.532 |
TRG_Pf-PMV_PEXEL_1 | 263 | 268 | PF00026 | 0.403 |
TRG_Pf-PMV_PEXEL_1 | 9 | 14 | PF00026 | 0.703 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJL0 | Leptomonas seymouri | 70% | 98% |
A0A0S4IX78 | Bodo saltans | 46% | 100% |
A0A1X0P532 | Trypanosomatidae | 55% | 100% |
A0A3Q8IJR7 | Leishmania donovani | 89% | 100% |
A0A422NK65 | Trypanosoma rangeli | 50% | 100% |
A4IBU5 | Leishmania infantum | 89% | 100% |
C9ZYR7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AFN2 | Leishmania major | 88% | 100% |
E9B6T5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5C2Q7 | Trypanosoma cruzi | 53% | 100% |